28
Growth Score
pts
Heat Score
-15 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
4235725
ValiPharma develops therapeutics and diagnostics based on epigenomics for the detection and treatment of cancer.
Satu Vainikka: CEO- J. Micallef: COO
About the Company
Cronos Therapeutics, Ltd., a biopharmaceutical company, develops therapeutics and diagnostics based on epigenomics for the detection and treatment of cancer. Its GeneICE compounds represent a way of treating diseases by acting to shut down harmful genes and therefore prevent their expression. The company's HyperGenomics platform characterizes
disease state by detecting areas on the chromosome where genes are active. Its compound, which is undergoing development, acts to shut down the Bcl-2 gene. Cronos Therapeutics, Ltd. was founded in 2004 and is based in London, the United Kingdom. As of October 3, 2006, Cronos Therapeutics Ltd. is a subsidiary of ValiRX PLC.
